REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $33,201,846 | +796.1% | 325,636 | +699.1% | 0.04% | +700.0% |
Q1 2023 | $3,704,990 | +401.2% | 40,750 | +109.4% | 0.01% | +400.0% |
Q4 2022 | $739,285 | +51.2% | 19,460 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $489,029 | +51.4% | 19,460 | +83.2% | 0.00% | 0.0% |
Q2 2022 | $323,000 | -7.2% | 10,625 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $348,000 | +24.3% | 10,625 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $280,000 | -73.9% | 10,625 | -0.5% | 0.00% | -50.0% |
Q3 2021 | $1,074,000 | -29.7% | 10,676 | -1.1% | 0.00% | -33.3% |
Q2 2021 | $1,528,000 | +88.4% | 10,795 | +32.6% | 0.00% | +50.0% |
Q1 2021 | $811,000 | -84.0% | 8,139 | -80.1% | 0.00% | -80.0% |
Q4 2020 | $5,060,000 | -37.8% | 40,925 | -51.0% | 0.01% | -44.4% |
Q3 2020 | $8,139,000 | +0.0% | 83,551 | +60.2% | 0.02% | -5.3% |
Q2 2020 | $8,136,000 | -26.5% | 52,146 | -32.0% | 0.02% | -36.7% |
Q1 2020 | $11,066,000 | -41.2% | 76,667 | -16.7% | 0.03% | -23.1% |
Q4 2019 | $18,817,000 | +2872.7% | 92,047 | +1066.8% | 0.04% | +3800.0% |
Q3 2019 | $633,000 | -14.9% | 7,889 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $744,000 | +14.8% | 7,889 | +4.1% | 0.00% | +100.0% |
Q1 2019 | $648,000 | +49.7% | 7,578 | -1.9% | 0.00% | 0.0% |
Q4 2018 | $433,000 | -26.5% | 7,721 | +7.1% | 0.00% | 0.0% |
Q3 2018 | $589,000 | +176.5% | 7,210 | +18.3% | 0.00% | – |
Q2 2018 | $213,000 | – | 6,096 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
IFP Advisors, Inc | 300 | $51,708 | 0.00% |